Last reviewed · How we verify
NCT04710147: S-CB&M
Cross-cultural Adaptation to the Spanish Population and Validation of the Community Balance & Mobility Scale (S-CB&M)
trial in Brain Injury, Chronic in 100 participants. Completed in 30 August 2022.
15 June 2022
Quick facts
| Lead sponsor | University of Castilla-La Mancha |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 9 February 2021 |
| Primary completion | 15 June 2022 |
| Estimated completion | 30 August 2022 |
| Sites | 1 location across Spain |
Conditions studied
- Brain Injury, Chronic — all drugs for Brain Injury, Chronic →
Sponsor
University of Castilla-La Mancha
Who can join
Adults 18 to 65, any sex, with Brain Injury, Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Due to acquired brain injury (ABI), is often difficulty in gait and balance alterations, as problems that patients designated as the most disabling. It is essential to an effective assessment of the balance. Objective: The purpose of the present project adapt and verify the validity of the scale Community Balance and Mobility (CB\&M), in patients with ABI in subacute and chronic stage, since that is postulated as a brief tool and covering the peculiarities of the specific alterations of the patient after suffering brain injury. Methodology: Between February 2021 and June 2022 will be transcultural adaptation to the ABI population and validation of psychometric scale CB\&M in three phases. 100 subjects who receive treatment in centers of attention to brain injury in Spain will be recruited. Results: validity and reliability parameters shall be calculated by means of descriptive statistics for each item of the scales and the set of scale score. Investigators will also analyze the internal consistency using Cronbach's alpha, the interclass correlation coefficient will be used to determine the reliability, and the items will be scanned with the Pearson coefficient: \> 0.20, among other parameters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04710147
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Castilla-La Mancha trials
Trials by the same sponsor.
- NCT07487857 — Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07419035 — Bipolar Radiofrequency for Genitourinary Syndrome of Menopause · NA · not yet recruiting
- NCT07452172 — Lumbar and Gluteal Motor Control in Chronic Low Back Pain · NA · not yet recruiting
- NCT07041944 — HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07091461 — HOMe-IMprove Telerrehabilitation System · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04710147 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Castilla-La Mancha
- Last refreshed: 4 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710147.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing